TB-500 (Thymosin Beta-4) - 10mg

Thymosin Beta-4 binds G-actin and acts as a major intracellular regulator of actin polymerisation — the cellular process behind migration, proliferation, and morphological change. Through this and related pathways, TB4 influences angiogenesis, modulates inflammation, and recruits progenitor cells to sites of injury. TB-500 is widely used as a functional research analogue, though the precise relationship between the synthetic peptide and full-length TB4 in vivo remains an active area of investigation.

TB-500 and TB4 have been the subject of small early-phase human trials, primarily in dermal and ophthalmic wound healing contexts. Most data remains preclinical, with no broad regulatory approval to date.

Cardiac repair: Animal studies on myocardial infarction recovery, including effects on cardiomyocyte survival and angiogenesis.
Dermal wound healing: Faster re-epithelialisation and reduced inflammation in cutaneous wound models.
Corneal and ocular research: Effects on corneal epithelial healing.
Musculoskeletal injury: Investigation in soft tissue and tendon repair models.
Hair follicle research: Studies on follicle stem cell activation and hair growth in animal models.